JEFFERY JOHNSON: Open Payments
NPI 1609887801 · EAGLE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 26 payments from 12 companies in 2025. Trend: 2023 $387 · 2024 $440 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $106 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| Janssen Pharmaceuticals, Inc | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Neurocrine BioSciences, Inc. | 2 | $43 |
| Tris Pharma Inc | 2 | $43 |
| Vanda Pharmaceuticals Inc. | 2 | $43 |
| ABBVIE INC. | 2 | $39 |
| Collegium Pharmaceutical, Inc. | 2 | $28 |
| Alkermes, Inc. | 1 | $26 |
Products named: TRINTELLIX, REXULTI, CAPLYTA, INGREZZA, Dyanavel XR, FANAPT, VRAYLAR, INVEGA SUSTENNA.
Industry payments across ID — which companies pay providers there.
